Functional characterization of CYP2D7 gene variants

Marin M. Jukic, Volker M. Lauschke, Takahiro Saito, Masahiro Hiratsuka, Magnus Ingelman-Sundberg

Research output: Contribution to journalArticle

Abstract

The ultrarapid CYP2D6 metabolizer (UM) phenotype is caused by CYP2D6 gene duplications in some, but not all, UM individuals. CYP2D6 and the adjacent pseudogene CYP2D7 are highly homologous; however, CYP2D7 harbors a premature stop codon, which is absent in carriers of the rare CYP2D7 variant rs530303678. We addressed whether rs530303678 could generate a functionally active protein, causing the UM phenotype. However, unlike CYP2D6 variants, two CYP2D7 rs530303678 variant isoforms, previously described in liver, showed neither significant protein expression nor catalytic activity toward the CYP2D6 substrates bufuralol or dextromethorphan. We conclude that loss of the stop codon in CYP2D7 does not result in the generation of enzymatically active protein in human liver and thus, cannot cause the UM phenotype.

Original languageEnglish
Pages (from-to)931-936
Number of pages6
JournalPharmacogenomics
Volume19
Issue number12
DOIs
Publication statusPublished - 2018 Jan 1

Keywords

  • CYP2D6
  • CYP2D7
  • bufuralol
  • dextromethorphan
  • ultrarapid metabolizam

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmacology

Fingerprint Dive into the research topics of 'Functional characterization of CYP2D7 gene variants'. Together they form a unique fingerprint.

  • Cite this

    Jukic, M. M., Lauschke, V. M., Saito, T., Hiratsuka, M., & Ingelman-Sundberg, M. (2018). Functional characterization of CYP2D7 gene variants. Pharmacogenomics, 19(12), 931-936. https://doi.org/10.2217/pgs-2018-0065